Legal Representation
Attorney
David M. Perry
USPTO Deadlines
Next Deadline
474 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-10-27)
Due Date
October 27, 2026
Grace Period Ends
April 27, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 27, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Nov 22, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Nov 22, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Nov 22, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Nov 22, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Nov 22, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Oct 27, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 25, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Sep 24, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Sep 8, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Sep 8, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sep 8, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Sep 8, 2020 | SNEA | W | SU-EXAMINER'S AMENDMENT WRITTEN |
| Mar 4, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Mar 4, 2020 | GNFR | O | FINAL REFUSAL E-MAILED |
| Mar 4, 2020 | CNFR | W | SU - FINAL REFUSAL - WRITTEN |
| Feb 12, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 12, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 10, 2020 | ALIE | A | ASSIGNED TO LIE |
| Feb 4, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 5, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 5, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 5, 2019 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| Jul 16, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jul 16, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 25, 2019 | IUAF | S | USE AMENDMENT FILED |
| Jun 25, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Dec 4, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 30, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 30, 2018 | EXT1 | S | SOU EXTENSION 1 FILED |
| Nov 30, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 10, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| May 15, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 15, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 25, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 11, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 6, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 12, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 30, 2017 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of atrophic dermal scarring, acne scarring, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Injectable dermal fillers
First Use Anywhere:
Jan 31, 2017
First Use in Commerce:
Jan 31, 2017
Classification
International Classes
005